# PopVax offers personalized cancer vaccine manufacturing at expected $300,000 cost

_Published Friday, October 30, 2026 at 11:54 AM EDT · Science, Products · Latest · Tier 2 — Notable_

![RNA Foundry, Personalized Cancer Vaccines, from PopVax and Stochastic, beside a photograph of an operator loading flasks at the RNA Foundry. — Primary](https://rnafoundry.com/assets/og-image.jpg)

PopVax's RNA Foundry is offering contract development and manufacturing of personalized cancer vaccine candidates at its Hyderabad facility. The company expects most projects to cost around $300,000 and take 8-10 weeks, depending on manufacturing slot availability.

Customers can submit an mRNA sequence or commission a design based on tumour sequencing data. The facility manufactures the RNA, packages it in lipid particles and tests the finished vials before shipment, supplying manufacturing records and analytical results for research and regulatory filings.

The company says it has capacity to make 100+ personalized cancer vaccines over the next 12 months. It describes compassionate use and expanded-access INDs as pathways patients and physicians are pursuing to access this class of medicine.

## Sources

- [rnafoundry.com](https://rnafoundry.com)

---
Canonical: https://techandbusiness.org/newswire/Uo5ilGy2EMXh_gvr_sb1Wu
Published: 2026-10-30T15:54:48.634Z
Story chronology: 2026-10-30T15:29:08.000Z
Retrieved: 2026-10-30T18:52:19.380Z
Publisher: Tech & Business (techandbusiness.org)